Treatment Protocols and Toolkits
Statements about products, investigational or pipeline products in development, or potential products (for purposes of this notice, hereinafter "products") are assumptions for informational and educational purposes only. Statements about products are guided by, and derived from, findings of preliminary and ongoing research, studies and/or trials, or informational and materials disclosed to Indivior and subject to modification or deletion based upon additional findings and/or results and/or information. No claims are being made with respect to any product.
Use drop-down menu to narrow list of publications.
0 resources
Opioid Use Disorder
California Bridge Program—HCP driven materials
CA Bridge - Bridge to Treatment
Access ResourceBoston Medical Center: Grayken Center for Addiction Training & Technical Assistance
Grayken Center for Addiction TTA | Boston Medical Center (addictiontraining.org)
Access ResourceYale—ED initiated buprenorphine
ED-Initiated Buprenorphine < ED-Initiated Buprenorphine (yale.edu)
Access ResourceMETA—PHI (Canada)
Toolkits - META:PHI (metaphi.ca)
Access ResourceKaiser Permanente: OUD Diagnosis & Treatment Guideline
Opioid Use Disorder Diagnosis and Treatment Guideline | Kaiser Permanente Washington
Access ResourceASAM Treatment in Correctional Settings Toolkit
Treatment in Correctional Settings (asam.org)
Access ResourceOverdose Reversal
META—PHI (Canada)
Toolkits - META:PHI (metaphi.ca)
Access Resource